Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly Bolotin

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
The Journal of Infection|June 16, 2026
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virusVajini N Atukorale, Jeffrey C Kwong, Alejandro Hernandez, et al.
CMAJ Open|December 23, 2017
Case-control study of household contacts to examine immunological protection from <i>Bordetella pertussis</i> transmission - study protocolShelly Bolotin, Caitlin Johnson, Susan Quach, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Vaccine|March 21, 2026
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD CohortRilwan Azeez, Spencer R Ames, Larisa C Lotoski, et al.
Vaccine|May 15, 2025
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health OrganizationAnshu Varma, Shelly Bolotin, Gaston De Serres, et al.
The Journal of Infectious Diseases|April 13, 2022
In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-AnalysisShelly Bolotin, Selma Osman, Stephanie L Hughes, et al.
CMAJ Open|April 4, 2023
Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence studyAndrea Atkinson, Arianne Albert, Elisabeth McClymont, et al.
Epidemiology and Health|October 19, 2023
Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD CohortRilwan Azeez, Larisa Lotoski, Aimée Dubeau, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of Infection|June 16, 2026
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virusVajini N Atukorale, Jeffrey C Kwong, Alejandro Hernandez, et al.
CMAJ Open|December 23, 2017
Case-control study of household contacts to examine immunological protection from <i>Bordetella pertussis</i> transmission - study protocolShelly Bolotin, Caitlin Johnson, Susan Quach, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 4, 2022
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysisKevin Yau, Christopher T Chan, Kento T Abe, et al.
JAMA Network Open|September 2, 2021
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing HemodialysisKevin Yau, Kento T Abe, David Naimark, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
Vaccine|March 21, 2026
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD CohortRilwan Azeez, Spencer R Ames, Larisa C Lotoski, et al.
Vaccine|May 15, 2025
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health OrganizationAnshu Varma, Shelly Bolotin, Gaston De Serres, et al.
The Journal of Infectious Diseases|April 13, 2022
In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-AnalysisShelly Bolotin, Selma Osman, Stephanie L Hughes, et al.
CMAJ Open|April 4, 2023
Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence studyAndrea Atkinson, Arianne Albert, Elisabeth McClymont, et al.
Epidemiology and Health|October 19, 2023
Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD CohortRilwan Azeez, Larisa Lotoski, Aimée Dubeau, et al.
Pageof 9